Complex peptidyl nucleoside antibiotics: Efficient syntheses of the glycosyl nucleoside amino acid cores

Journal of Organic Chemistry

Volumn 69, Issue 25, 2004, Pages 8594-8601

  Bhaket, Pushpal ^a   Stauffer, Christina S ^a   Datta, Apurba ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOLS; AMINO ACIDS; COMPLEXATION; GLUCOSE; SYNTHESIS (CHEMICAL);

ANANTIOPURE FURANOSYL; CHIRAL TEMPLATES; PEPTIDYL NUCLEOSIDE ANTIBIOTICS;

ANTIBIOTICS;

AMINO ACID; ANTIBIOTIC AGENT; NATURAL PRODUCT; NUCLEOSIDE; PEPTIDYLNUCLEOSIDE; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; ANALYTIC METHOD; ANTIFUNGAL ACTIVITY; ARTICLE; CHIRALITY; COMPLEX FORMATION; OPPORTUNISTIC INFECTION; RESEARCH; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; SYNTHESIS;

ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTIFUNGAL; CRYSTALLOGRAPHY, X-RAY; HUMANS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PEPTIDES; PUROMYCIN AMINONUCLEOSIDE; STEREOISOMERISM;

EID: 10044297409     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo048586l     Document Type: Article

References (45)

1. (a) Isono, K. J. Antibiot. 1988, 41, 1711-1739.
2. (b) Isono, K. Pharmacol. Ther. 1991, 52, 269-286.
3. Gooday, G. W. In Biochemistry of Cell Walls and Membranes in Fungi; Kuhn, P. J., Trinci, A. P., Jung, M. J., Goosey, M. W., Copping, L. G., Eds.; Springer: Berlin, 1990; p 61.
4. (a) Behr, J. B. Curr. Med. Chem.-Anti-Infect. Agents 2003, 2, 173-189.
5. (b) Ruiz-Herrera, J.; San-Blas, G. Curr. Drug Targets: Infect. Disord. 2003, 3, 77-91.
6. (c) Andriole, V. T. Int. J. Antimicrob. Agents 2000, 16, 317-321.
7. (a) Becker, J. M.; Covert, N. L.; Shenbagamurthi, P. S.; Steinfeld, A.; Naider, F. Antimicrob. Agents Chemother. 1983, 23, 926-929.
8. (b) Krainer, E.; Becker, J. M.; Naider, F. J. Med. Chem. 1991, 34, 174-180 and references therein.
9. (c) Chapman, T.; Kinsman, O.; Houston, J. Antimicrob. Agents Chemother. 1992, 36, 1909-1914.
10. (d) Chander, F. W. In Current Topics in Medical Mycology; Mcginnis, M., Ed.; Springer-Verlag: New York, 1985; Vol. 1, pp 1-23.
11. (e) Becker, J. M.; Marcus, S.; Tullock, J.; Miller, D.; Krainer, E.; Khare, R. K.; Naider, F. J. Infect. Dis. 1988, 157, 212-214.
12. (f) Hector, R. F.; Zimmer, B. L.; Pappagianis, D. Antimicrob. Agents Chemother. 1990, 34, 587-593.
13. (g) Hector, R. F.; Zimmer, B. L.; Pappagianis, D. In Recent Progress in Antifungal Chemotherapy; Yamaguchi, H., Kobayashi, G. S., Takahashi, H., Eds.; Dekker: New York, 1992; p 341.
14. (h) Clemons, K. V.; Stevens, D. A. Antimicrob. Agents Chemother. 1997, 41, 2026-2028.
15. (i) Graybill, J. R.; Najvar, L. K.; Bocanegra, R.; Hector, R. F.; Luther, M. F. Antimicrob. Agents Chemother. 1998, 42, 2371-2374.
16. (j) Sweezy, R. R.; Hector, R. F.; Khandwala, A.; Sinha, S.; Carlson, T.; Charney, M. R. 37th ICAAC, 1997, Abs. No. F87.
17. (k) Hector, R. F.; Schaller, K. Antimicrob. Agents Chemother. 1992, 36, 1284-1289.
18. For reviews, see: (a) Zhang, D.; Miller, M. J. Curr. Pharm. Des. 1999, 5, 73-99.
19. (b) Knapp, S. Chem. Rev. 1995, 95, 1859-1876.
20. (c) Garner, P. In Studies in Natural Products Chemistry; Atta-ur-Rahman, Ed.; Elsevier: Amsterdam, 1988; Part A, Vol. 1, pp 397-435, and references therein.
21. For representative examples, see: (a) Kuzuhara, H.; Ohrui, H.; Emoto, S. Tetrahedron Lett. 1973, 14, 5055-5058.
22. (b) Dondoni, A.; Franco, S.; Junquera, F.; Merchan, F. M.; Merino, P.; Tejero, T. J. Org. Chem. 1997, 62, 2, 5497-5507.
23. (c) Kato, K.; Chen, C. Y.; Akita, H. Synthesis 1998, 1527-1533.
24. (d) Chen, A.; Thomas, E. J.; Wilson, P. D. J. Chem. Soc., Perkin Trans. 1 1999, 3305-3310.
25. (e) Kutterer, K. M. K.; Just, G. Heterocycles 1999, 51, 1409-1420.
26. (f) Ghosh, A. K.; Wang, Y. J. Org. Chem. 1999, 64, 2789-2795.
27. (g) Gonda, J.; Martinkova, M.; Walko, M.; Zavacka, E.; Budesinsky, M.; Cisarova, I. Tetrahedron Lett. 2001, 42, 4401-4404.
28. Garner, P.; Park, J. M. J. Org. Chem. 1990, 55, 3772-3787.
29. Garner, P. Tetrahedron Lett. 1984, 25, 5855-5858.
30. Garner, P.; Yoo, J. K.; Sarabu, R.; Kennedy, V. O.; Youngs, W. J. Tetrahedron 1998, 55, 9303-9316.
31. For some recent studies, see: (a) Khalaf, J. K.; Datta, A. J. Org. Chem. 2004, 69, 387-390.
32. (b) Stauffer, C. S.; Datta, A. Tetrahedron 2002, 58, 9765-9767.
33. (c) Ravi Kumar, J. S.; Roy, S.; Datta, A. Tetrahedron 2001, 57, 1169-1173.
34. (d) Veeresa, G.; Datta, A. J. Org. Chem. 2000, 65, 7609-7611 and references therein.
35. For addition of vinylmagnesium bromide, see: (a) Tamamura, H.; Yamashita, M.; Nakajima, Y.; Sakano, K.; Otaka, A.; Ohno, H.; Ibuka, T.; Fujii, N. J. Chem. Soc., Perkin Trans. I 1999, 2983-2996.
36. (b) Ojima, I.; Vidal, E. S. J. Org. Chem. 1998, 63, 7999-8003 and references therein. For addition of allylmagnesium bromide, see:
37. (c) Jackson, M. D.; Gould, S. J.; Zabriskie, T. M. J. Org. Chem. 2002, 67, 2934-2941.
38. (a) Pattenden, G.; Plowright, A. T. Tetrahedron Lett. 2000, 41, 983-986.
39. (b) Roush, W. R.; Hunt, J. A. J. Org. Chem. 1995, 60, 798-806.
40. (c) Hafner, A.; Duthaler, R. O.; Marti, R.; Rihs, G.; Rothe-Streit, P.; Schwarzenbach, F. J. Am. Chem. Soc. 1992, 114, 2321-2336.
41. Collier, P. N.; Campbell, A. D.; Patel, I.; Raynham, T. M.; Taylor, R. J. K. J. Org. Chem. 2002, 67, 1802.
42. Campbell, J. E.; Englund, E. E.; Burke, S. D. Org. Lett. 2002, 4, 2273.
43. For a similar lactonization approach, see: Ghosh, A. K.; Cappielo, J.; Shin, D. Tetrahedron Lett. 1998, 39, 4651-4654.
44. Hanessian, S. Total Synthesis of Natural Products: The "Chiron" Approach; Pergamon Press: Oxford, 1983.
45. For a review, see: Vorbrüggen, H.; Ruh-Polenz, C. Org. React. 2000, 55, 1-654.